IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Q1 2019 Holdings

Filed 2019-05-15 | 29 holdings | $698.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$486.4M4,132,44269.6%
Biocryst Pharmaceuticals(BCRX)COM09058V103$70.5M8,659,98310.1%
Axsome Therapeutics Inc(AXSM)COM05464T104$46.9M3,293,7896.7%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$42.7M1,875,2096.1%
Arvinas Inc(ARVN)COM04335A105$31.6M2,138,4124.5%
Alector Inc(ALEC)COM014442107$18.7M1,000,0002.7%
Wave Life Sciences LTD(WVE)SHSY95308105$302.1K7,775,2070.0%
Synthorx IncCOM87167A103$198.1K9,724,5980.0%
Zogenix IncCOM NEW98978L204$131.0K2,382,1680.0%
RA Pharmaceuticals IncCOM74933V108$108.8K4,858,2600.0%
Inflarx NV(IFRX)COMN44821101$106.2K2,810,7080.0%
Orchard Therapeutics PLCADS68570P101$91.3K5,108,3300.0%
Eidos Therapeutics Inc(EIDXGBP)COM28249H104$91.1K2,162,6710.0%
Myovant Sciences LTDCOMG637AM102$84.6K3,544,2270.0%
TG Therapeutics Inc(TGTX)COM88322Q108$65.9K8,198,3370.0%
Sage Therapeutics Inc(SG7)COM78667J108$61.1K384,0010.0%
Rhythm Pharmaceuticals Inc(RYTM)COM76243J105$51.7K1,884,7820.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$41.2K1,441,0700.0%
Kala Pharmaceuticals IncCOM483119103$37.5K4,537,4780.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$37.3K2,563,6570.0%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$36.0K2,456,6690.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$33.8K2,415,4580.0%
Precision Biosciences IncCOM74019P108$33.1K1,842,3660.0%
Moderna Inc(MRNA)COM60770K107$30.8K1,513,9290.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$24.8K2,610,5100.0%
Solid Biosciences IncCOM83422E105$24.7K2,689,4440.0%
Shockwave MED Inc(SWAVUSD)COM82489T104$16.6K495,6080.0%
Scpharmaceuticals Inc(SCPH)COM810648105$8.6K2,857,1430.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$6.0K363,0510.0%